# MYOZ2

## Overview
MYOZ2 is a gene that encodes the protein myozenin 2, a myofibrillar protein predominantly expressed in cardiac and skeletal muscle tissues. Myozenin 2 is integral to the structural organization and function of muscle fibers, particularly at the Z-disc, where it interacts with proteins such as α-actinin and γ-filamin. This protein plays a crucial role in muscle contraction and is involved in the regulation of muscle fiber differentiation through its interaction with calcineurin, a key phosphatase in calcium signaling pathways (Wan2013Molecular; Murgia2021Protein). The MYOZ2 gene is implicated in various muscle-related pathologies, including hypertrophic cardiomyopathy and adolescent idiopathic scoliosis, highlighting its significance in maintaining normal muscle structure and function (Ruggiero2012Pathogenesis; Gao2024Tension).

## Structure
The MYOZ2 protein, also known as myozenin 2, is a 264 amino acid protein with a molecular weight of approximately 30.0 kDa and an isoelectric point of 6.99 (Wan2013Molecular). The primary structure of MYOZ2 includes several potential phosphorylation sites, although it lacks signal peptides and transmembrane regions (Wan2013Molecular). The secondary structure is predominantly composed of alpha-helices and random coils (Wan2013Molecular). 

MYOZ2 contains a conserved calsarcin domain, which is crucial for its role as a calcineurin-binding protein. This domain is involved in signal transduction related to cardiac muscle hypertrophy and slow fiber gene expression in skeletal muscle (Wan2013Molecular). The protein localizes to the Z-disk in muscle cells, where it interacts with other proteins such as α-actinin and γ-filamin, indicating its role in the structural organization of the Z lines (Takada2001Myozenin:; Hoshijima2006Mechanical). 

MYOZ2 is expressed in cardiac and slow skeletal muscles, and its absence can lead to exaggerated cardiac hypertrophy under stress, highlighting its importance in modulating calcium-calcineurin-dependent signaling (Hoshijima2006Mechanical).

## Function
MYOZ2, also known as myozenin 2, is a protein primarily expressed in cardiac and skeletal muscle, where it plays a crucial role in muscle function by interacting with other proteins at the Z-disc, a structure important for muscle contraction (Wan2013Molecular). MYOZ2 is categorized as a myofibrillar protein, indicating its involvement in the structural and functional aspects of muscle fibers (Murgia2021Protein). It is enriched in type 1/slow muscle fibers, suggesting a specific role in these fiber types (Murgia2021Protein).

In skeletal muscle, MYOZ2 is involved in myoblast differentiation and myotube formation, processes essential for muscle development and regeneration. It is regulated by the transcription factor MEF2A, which binds to the MYOZ2 promoter to control its expression (Wang2018Myocyte). MYOZ2's interaction with calcineurin, a protein phosphatase, suggests its role in muscle fiber differentiation by inhibiting calcineurin activity, which is crucial for the transition between muscle fiber types (Wan2013Molecular).

In cardiac muscle, MYOZ2 is implicated in maintaining sarcomere integrity and regulating signaling pathways that influence muscle growth and repair, contributing to normal cardiac structure and function (Ruggiero2012Pathogenesis).

## Clinical Significance
Mutations in the MYOZ2 gene, which encodes the Z disk protein myozenin 2, have been implicated in hypertrophic cardiomyopathy (HCM), a genetic disorder characterized by unexplained cardiac hypertrophy, myocyte disarray, and interstitial fibrosis. Two specific mutations, S48P and I246M, have been identified in individuals with HCM. These mutations affect highly conserved amino acids, suggesting their critical role in the disease's pathology (Osio2007Myozenin). Studies using transgenic mice models have shown that these mutations lead to cardiac hypertrophy, increased interventricular septal thickness, and left ventricular mass, independent of calcineurin activity, a known pro-hypertrophic signaling pathway (Ruggiero2012Pathogenesis). Instead, abnormalities in the Z disks, where MYOZ2 proteins co-localize with α-ACTININ, might trigger cardiac hypertrophy (Ruggiero2012Pathogenesis).

Alterations in MYOZ2 expression have also been linked to adolescent idiopathic scoliosis (AIS). In AIS patients, MYOZ2 expression levels differ significantly between the concave and convex sides of the spine, correlating with muscle fiber transformation. This suggests that MYOZ2 plays a role in the progression of spinal curvature in AIS (Gao2024Tension).

## Interactions
MYOZ2, or myozenin 2, is a protein that interacts with several key structural proteins in muscle cells, particularly at the Z-disc. It binds to alpha-actinin and gamma-filamin, two proteins crucial for the structural integrity of the Z-disc in skeletal muscle. MYOZ2 competitively binds these proteins, as demonstrated by co-immunoprecipitation experiments, which show that increasing the amount of alpha-actinin decreases the co-immunoprecipitation of gamma-filamin and vice versa, indicating competitive binding (Takada2001Myozenin:).

MYOZ2 also interacts with calcineurin, a phosphatase involved in calcium signaling, and inhibits its activity, thereby regulating muscle fiber differentiation. This interaction is significant in the context of muscle growth and development, as MYOZ2 expression affects myoblast proliferation and differentiation (Zhang2024DIABased).

In the cardiac context, MYOZ2 mutations, such as S48P and I246M, have been studied for their role in hypertrophic cardiomyopathy. These mutations lead to structural changes in the heart, including poorly formed Z-disks and myofibrillar disarray, suggesting that MYOZ2 is integrated into the sarcomere structure and interacts with alpha-actinin at the Z-disks (Ruggiero2012Pathogenesis). These interactions highlight MYOZ2's role in maintaining muscle structure and function.


## References


[1. (Takada2001Myozenin:) Fumio Takada, Douglas L. Vander Woude, Hui-Qi Tong, Terri G. Thompson, Simon C. Watkins, Louis M. Kunkel, and Alan H. Beggs. Myozenin: an α-actinin- and γ-filamin-binding protein of skeletal muscle z lines. Proceedings of the National Academy of Sciences, 98(4):1595–1600, February 2001. URL: http://dx.doi.org/10.1073/pnas.98.4.1595, doi:10.1073/pnas.98.4.1595. This article has 14 citations.](https://doi.org/10.1073/pnas.98.4.1595)

[2. (Ruggiero2012Pathogenesis) Alessandra Ruggiero, Suet Nee Chen, Raffaella Lombardi, Gabriela Rodriguez, and Ali J. Marian. Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity. Cardiovascular Research, 97(1):44–54, September 2012. URL: http://dx.doi.org/10.1093/cvr/cvs294, doi:10.1093/cvr/cvs294. This article has 38 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/cvr/cvs294)

[3. (Murgia2021Protein) Marta Murgia, Leonardo Nogara, Martina Baraldo, Carlo Reggiani, Matthias Mann, and Stefano Schiaffino. Protein profile of fiber types in human skeletal muscle: a single-fiber proteomics study. Skeletal Muscle, November 2021. URL: http://dx.doi.org/10.1186/s13395-021-00279-0, doi:10.1186/s13395-021-00279-0. This article has 76 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s13395-021-00279-0)

4. (Gao2024Tension) Tension load affects MYOZ2 expression and mediates paraspinal myofiber transformation in adolescent idiopathic scoliosis. This article has 0 citations.

[5. (Hoshijima2006Mechanical) Masahiko Hoshijima. Mechanical stress-strain sensors embedded in cardiac cytoskeleton: z disk, titin, and associated structures. American Journal of Physiology-Heart and Circulatory Physiology, 290(4):H1313–H1325, April 2006. URL: http://dx.doi.org/10.1152/ajpheart.00816.2005, doi:10.1152/ajpheart.00816.2005. This article has 196 citations.](https://doi.org/10.1152/ajpheart.00816.2005)

[6. (Wan2013Molecular) Lu Wan, Jisi Ma, Nianlu Wang, Daihua Wang, and Gangyi Xu. Molecular cloning and characterization of different expression of myoz2 and myoz3 in tianfu goat. PLoS ONE, 8(12):e82550, December 2013. URL: http://dx.doi.org/10.1371/journal.pone.0082550, doi:10.1371/journal.pone.0082550. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0082550)

[7. (Zhang2024DIABased) Dan Zhang, Yaojing Yue, Chao Yuan, Xuejiao An, Tingting Guo, Bowen Chen, Jianbin Liu, and Zengkui Lu. Dia-based proteomic analysis reveals myoz2 as a key protein affecting muscle growth and development in hybrid sheep. International Journal of Molecular Sciences, 25(5):2975, March 2024. URL: http://dx.doi.org/10.3390/ijms25052975, doi:10.3390/ijms25052975. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25052975)

[8. (Wang2018Myocyte) Ya-Ning Wang, Wu-Cai Yang, Pei-Wei Li, Hong-Bao Wang, Ying-Ying Zhang, and Lin-Sen Zan. Myocyte enhancer factor 2a promotes proliferation and its inhibition attenuates myogenic differentiation via myozenin 2 in bovine skeletal muscle myoblast. PLOS ONE, 13(4):e0196255, April 2018. URL: http://dx.doi.org/10.1371/journal.pone.0196255, doi:10.1371/journal.pone.0196255. This article has 47 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0196255)

[9. (Osio2007Myozenin) Adriana Osio, Lily Tan, Suet N. Chen, Raffaella Lombardi, Sherif F. Nagueh, Sanjay Shete, Robert Roberts, James T. Willerson, and Ali J. Marian. Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circulation Research, 100(6):766–768, March 2007. URL: http://dx.doi.org/10.1161/01.res.0000263008.66799.aa, doi:10.1161/01.res.0000263008.66799.aa. This article has 156 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/01.res.0000263008.66799.aa)